Urology

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dalbagni G et al. – Conservative management of clinical T1 bladder cancer depends on careful selection and monitoring of patients. All patients being considered for conservative management should undergo restaging transurethral resection to allow for better risk assessment. Patients with T1 disease on restaging are at high risk of progression and should be considered for early cystectomy.

Related Articles

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer, 11/13/09    Relevance Score: 70%

Evidence-based Principles of Bladder Cancer and Diet
Urology, 10/21/09    Relevance Score: 70%

Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09    Relevance Score: 70%

Biomarkers in bladder cancer
BJU International, 10/01/09    Relevance Score: 70%

Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09    Relevance Score: 70%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address